Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for DiaMedica Therapeutics, Inc. (DMAC : NSDQ)

• Company Description    DiaMedica Therapeutics Inc. is a biopharmaceutical company. It engages in the development of novel recombinant proteins and monoclonal antibodies. The companys lead product principally consists DM199, a recombinant human tissue kallikrein-1 protein. It operates primarily in the United States and Canada. DiaMedica Therapeutics Inc. is headquartered in Minneapolis, Minnesota. Number of Employees: 15

• Price / Volume Information    Yesterday's Closing Price: $2.39 Daily Weekly Monthly 20 Day Moving Average: 57,035 shares Shares Outstanding: 26.44 (millions) Market Capitalization: $63.20 (millions) Beta: 2.31 52 Week High: $9.55 52 Week Low: $2.12 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 10.14% 20.68% 12 Week -15.25% -8.04% Year To Date -35.92% -23.80%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2 CARLSON PARKWAY SUITE 260 - MINNEAPOLIS,MN 55447 USA ph: 763-312-6755 fax: 763-710-4456 ir@diamedica.com http://www.diamedica.com

• General Corporate Information    Officers Rick Pauls - Chief Executive Officer; President and Director Richard Pilnik - Chairman Scott Kellen - Chief Financial Officer and Secretary Amy L. Burroughs - Director Michael Giuffre - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 25253X207 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/10/22 Share - Related Items Shares Outstanding: 26.44 Most Recent Split Date: 11.00 (0.05:1) Beta: 2.31 Market Capitalization: $63.20 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.16 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.68 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.55 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 31.58% vs. Previous Quarter: -30.00% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - -35.43 12/31/21 - -40.42 09/30/21 - -49.94 ROA 03/31/22 - -34.08 12/31/21 - -38.74 09/30/21 - -47.35 Current Ratio 03/31/22 - 29.37 12/31/21 - 29.82 09/30/21 - 29.89 Quick Ratio 03/31/22 - 29.37 12/31/21 - 29.82 09/30/21 - 29.89 Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Book Value 03/31/22 - 1.54 12/31/21 - 1.67 09/30/21 - 1.78 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.02 12/31/21 - 0.01 09/30/21 - 0.01

Powered by Zacks Investment Research ©